{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T13:28:42Z","timestamp":1648992522865},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1007\/bf03345158","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T14:52:34Z","timestamp":1397141554000},"page":"206-210","source":"Crossref","is-referenced-by-count":6,"title":["Acute goserelin administration inhibits gonadotropin and androgen secretion in post-menopausal women with ovarian hyperandrogenism"],"prefix":"10.1007","volume":"26","author":[{"given":"Cataldo","family":"Di Bisceglie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Brocato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tagliabue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bertagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gianotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ghigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Manieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,18]]},"reference":[{"key":"BF03345158_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/ajcp\/83.1.101","volume":"83","author":"G Madiedo","year":"1985","unstructured":"Madiedo G., Tieu T.M., Aiman, J. Atypical ovarian hyperthecosis in a virilized postmenopausal woman. Am. J. Clin. Pathol. 1985, 83: 101\u2013107.","journal-title":"Am. J. Clin. Pathol."},{"key":"BF03345158_CR2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1994.tb01820.x","volume":"41","author":"MM Pascale","year":"1994","unstructured":"Pascale M.M., Pugeat M., Roberts M., et al. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours. Clin. Endocrinol. (Oxf.) 1994, 41: 571\u2013576.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03345158_CR3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2265.1995.tb02931.x","volume":"43","author":"A Chico","year":"1995","unstructured":"Chico A., Garc\u00eda J.L., Matias-Guiu X., et al. A gonadotropin dependent stromal luteoma: a rare cause of post-menopausal virilization. Clin. Endocrinol. (Oxf.) 1995, 43: 645\u2013649.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03345158_CR4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF03350327","volume":"21","author":"C Manieri","year":"1998","unstructured":"Manieri C., Di Bisceglie C., Fornengo R., et al. Postmenopausal virilization in a woman with gonadotropin dependent ovarian hyperthecosis. J. Endocrinol. Invest. 1998, 21: 128\u2013132.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03345158_CR5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0025-6196(11)65035-0","volume":"75","author":"HC Taylor","year":"2000","unstructured":"Taylor H.C., Pillay I., Setrakian S. Diffuse stromal Leydig cell hyperplasia: a unique cause of postmenopausal hyperandrogenism and virilization. Mayo Clin. Proc. 2000, 75: 288\u2013292.","journal-title":"Mayo Clin. Proc."},{"key":"BF03345158_CR6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1420619","volume":"142","author":"MJ Pic\u00f3n","year":"2000","unstructured":"Pic\u00f3n M.J., Lara J.I., Sarasa J.L., et al. Use of a long-acting gonadotropin-releasing hormone analogue in a postmenopausal woman with hyperandrogenism due to a hilus cell tumour. Eur. J. Endocrinol. 2000, 142: 619\u2013622.","journal-title":"Eur. J. Endocrinol."},{"key":"BF03345158_CR7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/humupd\/6.4.322","volume":"6","author":"T Reissmann","year":"2000","unstructured":"Reissmann T., Schally A.V., Bouchard P., Riethm\u00fcller H., Engel J. The LHRH antagonist Cetrorelix: a review. Hum. Reprod. Update 2000, 6: 322\u2013331.","journal-title":"Hum. Reprod. Update"},{"key":"BF03345158_CR8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000019547","volume":"33","author":"HJ Voogt De","year":"1998","unstructured":"De Voogt H.J., Studer U., Schroder F.H., Klijn J.G., De Pauw M., Sylvester R. Maximum androgen blockade using LHRH agonist buserelin in combination with short-term (two weeks) or long-term (continuous) cyproterone acetate is not superior to standard androgen deprivation in the treatment of advanced prostate cancer. Final analysis of EORTC GU Group Trial 30843. European Organization for Research and Treatment of Cancer (EORTC). Genito-Urinary Tract Cancer Cooperative Group. Eur. Urol. 1998, 33: 152\u2013158.","journal-title":"Eur. Urol."},{"key":"BF03345158_CR9","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"24","author":"D Ferriman","year":"1961","unstructured":"Ferriman D., Gallwey J.D. Clinical assessment of body hair in women. J. Clin. Endocrinol. Metab. 1961, 24: 1440\u20131447.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345158_CR10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2265.1997.1050916.x","volume":"46","author":"JH Barth","year":"1997","unstructured":"Barth J.H., Jenkins M., Belchetz P.E. Ovarian hyperthecosis, diabetes and hirsuties in post-menopausal women. Clin. Endocrinol. (Oxf.) 1997, 46: 123\u2013128.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03345158_CR11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00006254-198905000-00008","volume":"44","author":"F Comite","year":"1989","unstructured":"Comite F. GnRH analogs and safety. Obstet. Gynecol. Surv. 1989, 44: 319\u2013325.","journal-title":"Obstet. Gynecol. Surv."},{"key":"BF03345158_CR12","first-page":"1169","volume":"80","author":"BR Carr","year":"1995","unstructured":"Carr B.R., Breslau N.A., Givens C., Byrd W., Barnett-Hamm C., Marshburn P.B. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study. J. Clin. Endocrinol. Metab. 1995, 80: 1169\u20131178.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345158_CR13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1056\/NEJM198908173210701","volume":"321","author":"M Kuhn","year":"1989","unstructured":"Kuhn M., Billebaud T., Navratil H., et al. Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide). N. Engl. J. Med. 1989, 321: 413\u2013418.","journal-title":"N. Engl. J. Med."},{"key":"BF03345158_CR14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000292725","volume":"34","author":"LH Honor\u00e9","year":"1992","unstructured":"Honor\u00e9 L.H., Chari R., Mueller H.D., Cumming D.C., Scott J.Z. Postmenopausal hyperandrogenism of ovarian origin. A clinicopathologic study of four cases. Gynecol. Obstet. Invest. 1992, 34: 52\u201356.","journal-title":"Gynecol. Obstet. Invest."},{"key":"BF03345158_CR15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00634494","volume":"256","author":"T Agorastos","year":"1995","unstructured":"Agorastos T., Argyriadis N., Fraggidis G., Vakiani A., Zournatzi V., Bontis J. Postmenopausal virilization due to ovarian hyperthecosis. Arch. Gynecol. Obstet. 1995, 256: 209\u2013211.","journal-title":"Arch. Gynecol. Obstet."},{"key":"BF03345158_CR16","first-page":"101","volume-title":"Reproductive endocrine therapeutics","author":"RA Lobo","year":"1988","unstructured":"Lobo R.A. Endocrine therapy of hyperandrogenism. In: Barbieri R.L., Schiff I. (Eds.), Reproductive endocrine therapeutics. Alan R. Liss, New York, 1988, p. 101."},{"key":"BF03345158_CR17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0015-0282(00)01645-9","volume":"75","author":"Z Efstathiadou","year":"2001","unstructured":"Efstathiadou Z., Tsatsoulis A. Long-term remission of ovarian hyperandrogenism after short-term treatment with a gonadotropin-releasing hormone agonist. Fertil. Steril. 2001, 75: 59\u201362.","journal-title":"Fertil. Steril."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03345158\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T06:25:28Z","timestamp":1558506328000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03345158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["BF03345158"],"URL":"https:\/\/doi.org\/10.1007\/bf03345158","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}